FDA advisers vote ‘no’ on drug that may slow Alzheimer’s progression
By
Alicia Lasek
Nov 09, 2020
If approved by the FDA, aducanumab would be the first-ever drug marketed to slow progression of the brain-wasting disease, according to its developer. But an advisory committee was unconvinced of the drug’s...
Alzheimer’s drug gets FDA support ahead of Friday vote on approval
By
Alicia Lasek
Nov 05, 2020
Documents released on Wednesday show that the agency’s staff members already are enthusiastic about the drug’s prospects. If approved, aducanumab could be the first drug on the market to slow Alzheimer’s...
First Alzheimer’s commercial blood test to detect amyloid beta hits the market
By
Alicia Lasek
Oct 29, 2020
A new blood test that detects the presence of Alzheimer’s brain plaques on Thursday became the first to hit the commercial market on a wide scale.
Rural seniors with dementia have longer nursing home stays, study finds
By
Alicia Lasek
Oct 23, 2020
Rural Medicare recipients with Alzheimer’s and related dementias have longer nursing home stays and shorter survival time following diagnosis than their urban peers, investigators say.
Falls may be an Alzheimer’s precursor, study finds
By
Alicia Lasek
Oct 14, 2020
Early brain changes may be the culprit when an older person with no signs of cognitive decline has a fall, researchers say. Such falls tend to occur about five years before memory loss and confusion arise.
Sleep apnea severity tied to greater buildup of Alzheimer’s brain plaques
By
Alicia Lasek
Sep 29, 2020
In a research first, Alzheimer’s-like amyloid plaques have been found in the brains of people with clinically verified obstructive sleep apnea, investigators say. CPAP treatment appeared to have...
Delayed cognitive decline linked to daily use of two languages
By
Alicia Lasek
Sep 21, 2020
People receive a later diagnosis of mild cognitive impairment when they actively speak two languages every day, investigators report.
Clinical briefs for Friday, Sept. 11
By
Kimberly Marselas
Sep 10, 2020
Urinary culture intervention leads to fewer antibiotic prescriptions … Sleep apnea tied to higher spine fracture risk in women … Scientists: Quiet zones in indoor spaces like dining rooms may limit...
Study to examine severe side effects tied to Alzheimer’s drug combo
By
Alicia Lasek
Sep 08, 2020
Millions of Medicare records will be used to analyze how two drug classes commonly used to treat Alzheimer’s may lead to a ‘prescription cascade’ when taken together.
Clinical briefs for Thursday, August 20
By
Alicia Lasek
Aug 20, 2020
Masks, protective gear remain hard to get for small buyers … Major coalition urges catch-up on missed vaccinations due to pandemic … ‘Failed’ Alzheimer’s research should be re-evaluated in light...